Colchicine reduces the activation of NLRP3 inflammasome in COVID-19 patients

ConclusionTreatment with colchicine inhibited the activation of the NLRP3 inflammasome, an event triggering the ‘cytokine storm’ in COVID-19.Trial registration numbersRBR-8jyhxh
Source: Inflammation Research - Category: Research Source Type: research